Global Toxoid Vaccine Market Research and Forecast, 2018-2023

Toxoid vaccine Market are biologically inactivated forms of native toxins. The market for toxoid vaccine is projected to be growing at a CAGR of 4.3% for the forecast 2018-2023. The most commonly used toxoid is tetanus toxoid, diphtheria-derived toxoids and other proteins are used occasionally. Diphtheria toxoid is produced globally in a standard fashion, in the US, production and testing procedures are specified in the Code of Federal Regulations. Diphtheria toxoid is manufactured both by large multinational vaccine companies and by developing countries for domestic use. Boostrix and Adacel are the examples and are approved for individuals 11 to 64 years of age.